FDA Inspection
NuCare Pharmaceuticals IncNuCare Pharmaceuticals Inc – FDA Inspection, Mar 12, 2025
Record Details
This FDA Inspection record concerns NuCare Pharmaceuticals Inc, with an inspection on March 12, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · fecdf1c4-f3ff-4e7c-b7d7-ce8fec6aeeb7
Inspection Facts
- Inspection number
- 1264447
- FDA center
- Human Drugs
Other FDA inspections of NuCare Pharmaceuticals Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2018 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NuCare Pharmaceuticals Inc
- FDA Inspection 1114915 - 2020-01-10
- FDA Inspection 1069414 - 2018-09-19
- FDA Inspection 1045177 - 2018-03-21
- FDA Inspection 920340 - 2015-02-13
- FDA Inspection 718535 - 2011-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.